Furthermore, based on the results of this study, the immunodiagnostic MDX cocktail containing antibodies against Melan-A, PNL2, TRP-1, and TRP-2 remains the gold standard for accurately differentiating OMMs from STS and other undifferentiated malignant neoplasms in a routine diagnostic setting. The gene discussed is TYRP1; the disease is cancer.